Outlook Therapeutics Inc (NASDAQ:OTLK) currently has a daily average trading volume of 442.77K but it saw 1363904 shares traded in last market. With a market cap of 77.13M USD, the company’s current market price of $1.80 came rising about 10.43 while comparing to the previous closing price of $1.63. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.25 and as low as $0.87.
BTIG Research upgraded its recommendation for the stock as a “Buy” from “Neutral” on March 27, 2024 while assigning a price target of $50. Chardan Capital Markets issued its recommendations for the stock as it upgraded the price target for the stock is $3.
Over the week, OTLK’s stock price is moving 10.43% up while it is 15.38% when we observe its performance for the past one month. Year-to-date it is -4.76% down and over the past year, the stock is showing a downside performance of -77.22%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.47 while estimate for next year EPS is -2.08. In next quarter, company is expected to be making quarterly sales of $6.76M as analysts are expecting the sales for current fiscal year at $7.28M and seeing the company making $34.93M in sales next year. Moreover, analysts are in estimates of $1.91M for current-quarter revenue.
Currently, Outlook Therapeutics Inc’s total number of outstanding shares is 32.91M with 28.16% of that held by the insiders while 16.81% of its common stock has been owned by the institutions. Stock’s beta reads 0.27. Its return on asset (ROA) is 54.08% on average.
